InsidersTradesSigma
Follow the Biota Pharmaceuticals, Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 9 February 2016 (Acquisition). Among the most active insiders: COLONNESE MARK P. The full history is accessible without an account.
Analysts rate Biota Pharmaceuticals, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Biota Pharmaceuticals, Inc.是一家专注于开发抗病毒治疗方法的公司。该公司在纳斯达克上市，股票代码为XNAS。